LAS VEGAS, NV, (December 29, 2025) — New Horizon Medical Solutions (NHMS) is excited to announce the acquisition of Applied Tissue Technologies' (ATT) business assets. ATT is a pioneering, 25-year-old wound care company based in Boston, Massachusetts. This strategic move aligns with NHMS's commitment to delivering cutting-edge products that enhance wound care management.
Key acquisition highlights
- Novel wound technologies
ATT has developed patented treatment methods and proprietary devices that empower caregivers to heal wounds more efficiently. Their technologies are designed for use in both established economic zones and in underserved areas, using non-powered and battery-powered solutions.
- Expert leadership
Elof Eriksson, MD, PhD, founder of ATT and a distinguished figure in the field of plastic and reconstructive surgery, has been instrumental in the development of these innovative products. He served as chief of plastic and reconstructive surgery at Brigham and Women's Hospital in Boston from 1986 to 2016 and held the prestigious Joseph E. Murray chair of plastic and reconstructive surgery at Harvard Medical School.
- Revolutionary wound dressing
Dr. Eriksson states, "We have developed a novel, simpler, and more predictable wound dressing that features a transparency unlike any other in the marketplace, which is what providers have been searching for."
For full press release, click here.